Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo

Abstract A specific contrast agent for magnetic resonance imaging (MRI) is crucial to brain tumor patients for the surgical operation or the postoperative radiology. This study explored lactoferrin-conjugated superparamagnetic iron oxide nanoparticles (Lf-SPIONs) as an MRI contrast agent for the det...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials Vol. 32; no. 2; pp. 495 - 502
Main Authors Xie, Hui, Zhu, Yanhong, Jiang, Weili, Zhou, Qing, Yang, Hai, Gu, Ning, Zhang, Yu, Xu, Huibi, Xu, Haibo, Yang, Xiangliang
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.01.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract A specific contrast agent for magnetic resonance imaging (MRI) is crucial to brain tumor patients for the surgical operation or the postoperative radiology. This study explored lactoferrin-conjugated superparamagnetic iron oxide nanoparticles (Lf-SPIONs) as an MRI contrast agent for the detection of brain gliomas in vivo . The hydrodynamic diameter of about 75 nm, saturation magnetization of 51 emu/g Fe and T2 relaxivity of 75.6 mM−1 S−1 of the Lf-SPIONs suggested its applicability for MRI. Using a rat model of C6 glioma, Lf-SPIONs provided a better picture or more sensitivity to depict brain glioma on MR images than that of SPIONs. Significantly enhanced T2 -weighted images of brain glioma were documented in vivo with Lf-SPIONs until 48 h after injection. Moreover, Lf-SPIONs were clearly observed around vascular region of the tumor slices after 48 h. High level expression of Lf receptors was confirmed in brain tumor tissues by RT-PCR and Western Blot compared to normal brain tissues. These findings suggested that Lf-SPIONs could be potentially employed as a sensitive and specific MRI contrast agent in the diagnosis of brain glioma.
Bibliography:http://dx.doi.org/10.1016/j.biomaterials.2010.09.024
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2010.09.024